Vandetanib alters the tumoricidal capacity of human breast cancer stem cells via inhibiting vasculogenic capacity

Sanya Haiaty ^1,2,3,4 , Mohammad-Reza Rashidi ¹, Maryam Akbarzadeh ^1,5, Ahad Bazmany ^6,3, Mostafa Mostafazadeh ², Saba Nikanfar ², Roya Shabkhizan ⁷, Rostam Rezaeian ³, Reza Rahbarghazi ^8,9 * , Mohammad Nouri ^1,2,8

Cited by CrossRef: 0

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate: 24%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded, Google Scholar; SJR ; Essential Science Indicators; Publons; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO; Ulrich
Member of COPE
Follower of ICMJE
Permission: Creative Commons